HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

sultamicillin (ampicillin-sulbactam)

Subscribe to New Research on sultamicillin

contains ampicillin & sulbactam

Also Known As:

ampicillin-sulbactam; Unasyn; CP 49,952; CP 49952; Combisid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (((3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-yl)carbonyl)oxy)methyl ester, S,S-dioxide, (2S-(2alpha(2R*,5S*),5alpha,6beta(S*)))-

Networked: 326 relevant articles (68 outcomes, 64 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1.	Lode, H: 4 articles (02/2008 - 09/2001)
2.	Allewelt, M: 3 articles (02/2008 - 10/2001)
3.	Doi, Yohei: 2 articles (05/2015 - 02/2011)
4.	Pasculle, Anthony W: 2 articles (05/2015 - 02/2011)
5.	Qureshi, Zubair A: 2 articles (05/2015 - 02/2011)
6.	Costa, S F: 2 articles (06/2014 - 06/2008)
7.	Paterson, David L: 2 articles (11/2013 - 02/2011)
8.	Coccolini, Federico: 2 articles (01/2013 - 01/2011)
9.	Berktaş, Mustafa: 2 articles (01/2013 - 10/2011)
10.	Ansaloni, Luca: 2 articles (01/2013 - 01/2011)

Related Diseases

1.	Infection 03/01/1993 - "We think that ampicillin/sulbactam combination is very effective in prevention and treatment of shunt infections." 04/01/1989 - "Sultamicillin has been shown to be clinically effective in non-comparative trials in patients with infections of the respiratory tract, ears, nose and throat, urinary tract, skin and soft tissues, as well as in obstetric and gynaecological infections, and in the treatment of gonorrhoea. " 01/01/1986 - "[Epidemiological and therapeutic studies of gonorrheal infection--clinical efficacy of sultamicillin]." 01/01/2002 - "Ampicillin/sulbactam has also proved effective in the prevention of post-operative surgical infections in pediatric patients. " 09/01/2001 - "The fractional inhibitory concentration indices were between 0.19 and 0.56 in combination with 6.25 and 25 mg/L EGCg, respectively, indicating that ampicillin/sulbactam and EGCg combination may be effective against MRSA infections."
2.	Respiratory Tract Infections (Respiratory Tract Infection) 01/01/1992 - "An open non-comparative pilot study of the safety and efficacy of oral sultamicillin in the treatment of mild to moderate upper respiratory tract infections in children." 09/01/1992 - "[An open non-comparative study of the efficacy and tolerability of sultamicillin in the therapy of respiratory infections in childhood]." 01/01/1992 - "Treatment of lower respiratory tract infections with sultamicillin." 11/01/1991 - "Ampicillin/sulbactam in lower respiratory tract infections: a review." 02/01/1991 - "[Clinical evaluation of sultamicillin in lower respiratory tract infections]."
3.	Endocarditis 10/01/1999 - "Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam." 01/01/1996 - "However, only the regimen of ampicillin-sulbactam in combination with vancomycin effectively prevented relapse of endocarditis posttherapy after a 5-day antibiotic-free period. " 04/01/1995 - "Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits." 01/01/1996 - "Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci." 06/01/1990 - "At a challenge inoculum of 10(6) CFU, vancomycin was 100% effective in preventing enterococcal endocarditis compared with ampicillin (29%; P less than 0.00001) and ampicillin-sulbactam (65%; P less than 0.01). "
4.	Soft Tissue Infections 01/01/1991 - "Ampicillin-sulbactam may be used for treatment of intraabdominal, gynecologic, urinary tract, and skin and soft tissue infections." 04/01/1987 - "Sultamicillin in the treatment of superficial skin and soft tissue infections in children." 12/01/2013 - "Thus, combination therapy with ampicillin-sulbactam and meropenem is effective against skin and soft tissue infection due to carbapenem-resistant A. " 08/01/2000 - "Ampicillin/sulbactam and cefoxitin were equally effective for the empirical treatment of cutaneous or other soft-tissue infections in injection drug abusers and patients who did not inject drugs." 12/01/2013 - "Combination therapy with intravenous ampicillin-sulbactam and meropenem may be an option for skin and soft tissue infections due to carbapenem-resistant A. "
5.	Urinary Tract Infections (Urinary Tract Infection) 07/01/1990 - "Sultamicillin, a new semisynthetic oral beta-lactam antibiotic, was evaluated for its antibacteria susceptibility and clinical efficacy against urinary tract infection (UTI), and the following results were obtained. " 04/01/1996 - "Sultamicillin is an efficacious treatment for acute urinary tract infections, like AMX/CLA. " 07/01/1990 - "[Clinical evaluation of sultamicillin in the treatment of urinary tract infections]." 01/01/1989 - "2) In total, 368 patients with complicated urinary tract infections were treated with 750-2250 mg/d of sultamicillin for 5 d. " 01/01/1989 - "Sultamicillin in the treatment of urinary tract infections."

Related Drugs and Biologics

1.	Ampicillin (Omnipen)
2.	sultamicillin (ampicillin-sulbactam)
3.	beta-Lactamases (beta-Lactamase)
4.	Clindamycin (Cleocin)
5.	Vancomycin
6.	Sulbactam
7.	Cefoxitin (Cefoxitin Sodium)
8.	Clavulanic Acid (Potassium Clavulanate)
9.	Gentamicins (Gentamicin)
10.	Cefuroxime (Zinacef)

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Cholecystectomy
3.	Cesarean Section (Caesarean Section)
4.	Tocolysis
5.	Antibiotic Prophylaxis